Neutrophil-to-Lymphocyte Ratio Predicts Early Mortality in Patients with HBV-Related Decompensated Cirrhosis
Table 1
Baseline demographic and clinical characteristics of cohort.
HBV-DeCi patients ()
Gender (male/female)
118/30
Age (y)
53.2 ± 11.2
Total protein (g/L)
61.0 ± 8.2
Albumin (g/L)
30.4 ± 5.9
ALT (U/L)
30.5 (17.0–55.0)
AST (U/L)
48.0 (29.0–79.0)
Total bilirubin (μmol/L)
50.5 (23.5–117.0)
INR
1.50 ± 0.40
Creatinine (mmol/L)
72.5 (60.0–88.0)
Platelet count (×109/L)
65.5 (38.0–113.5)
White blood cell count (×109/L)
4.35 (2.90–5.90)
Neutrophil count (×109/L)
2.40 (1.50–3.70)
Lymphocyte count (×109/L)
0.90 (0.60–1.40)
NLR
2.67 (1.46–4.39)
MELD score
13.4 ± 6.7
HBsAg positive
148
HBeAg positive
80
HBcAb IgM positive
0
HBV DNA positive
148
HE ()
3
Ascites ()
107
Variceal bleeding ()
40
HRS ()
29
Data are expressed as , mean ± SD, or median (interquartile range). ALT, alanine aminotransferase; AST, aspartate aminotransferase; INR, international normalized ratio; NLR, neutrophil-to-lymphocyte ratio; MELD score, model for end-stage liver disease score; HE, hepatic encephalopathy; HRS, hepatorenal syndrome.
